AU2005231476B2 - Il-28 and il-29 cysteine mutants for treating viral infection - Google Patents

Info

Publication number

AU2005231476B2

AU2005231476B2 AU2005231476A AU2005231476A AU2005231476B2 AU 2005231476 B2 AU2005231476 B2 AU 2005231476B2 AU 2005231476 A AU2005231476 A AU 2005231476A AU 2005231476 A AU2005231476 A AU 2005231476A AU 2005231476 B2 AU2005231476 B2 AU 2005231476B2

Authority

AU

Australia

Prior art keywords

cells

virus

polypeptide

seq

amino acid

Prior art date

2004-04-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• Discuss

• 208000036142 Viral infection Diseases 0.000 title abstract description 71
• 230000009385 viral infection Effects 0.000 title abstract description 71
• 235000018417 cysteine Nutrition 0.000 title description 35
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title description 33
• 230000000840 anti-viral effect Effects 0.000 claims abstract description 52
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 204
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 190
• 229920001184 polypeptide Polymers 0.000 claims description 188
• 229920001223 polyethylene glycol Polymers 0.000 claims description 105
• 238000000034 method Methods 0.000 claims description 99
• 239000002202 Polyethylene glycol Substances 0.000 claims description 70
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 48
• 239000003814 drug Substances 0.000 claims description 29
• 108010047761 Interferon-alpha Proteins 0.000 claims description 27
• 102000006992 Interferon-alpha Human genes 0.000 claims description 26
• 239000003443 antiviral agent Substances 0.000 claims description 23
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 claims description 22
• 229920003169 water-soluble polymer Polymers 0.000 claims description 20
• 239000003795 chemical substances by application Substances 0.000 claims description 18
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 17
• 208000005176 Hepatitis C Diseases 0.000 claims description 15
• 229920001427 mPEG Polymers 0.000 claims description 12
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 10
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 10
• 208000010710 hepatitis C virus infection Diseases 0.000 claims description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
• 229960000329 ribavirin Drugs 0.000 claims description 7
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 claims description 7
• 229940106366 pegintron Drugs 0.000 claims description 6
• 229940002988 pegasys Drugs 0.000 claims description 5
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims description 4
• 108010092851 peginterferon alfa-2b Proteins 0.000 claims description 3
• 229940123066 Polymerase inhibitor Drugs 0.000 claims 2
• 108010092853 peginterferon alfa-2a Proteins 0.000 claims 2
• 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 abstract description 357
• 102100020990 Interferon lambda-1 Human genes 0.000 abstract description 279
• 241000700605 Viruses Species 0.000 abstract description 93
• 101710099622 Interferon lambda-2 Proteins 0.000 abstract description 76
• 210000004185 liver Anatomy 0.000 abstract description 75
• 102100020989 Interferon lambda-2 Human genes 0.000 abstract description 74
• 101710099621 Interferon lambda-3 Proteins 0.000 abstract description 48
• 102100020992 Interferon lambda-3 Human genes 0.000 abstract description 46
• 241000700721 Hepatitis B virus Species 0.000 abstract description 39
• 241000711549 Hepacivirus C Species 0.000 abstract description 33
• 102000014150 Interferons Human genes 0.000 abstract description 29
• 108010050904 Interferons Proteins 0.000 abstract description 29
• 230000003612 virological effect Effects 0.000 abstract description 29
• 238000011282 treatment Methods 0.000 abstract description 27
• 229940079322 interferon Drugs 0.000 abstract description 17
• 241000894007 species Species 0.000 abstract description 11
• 206010061598 Immunodeficiency Diseases 0.000 abstract description 9
• 230000001028 anti-proliverative effect Effects 0.000 abstract description 4
• 230000001506 immunosuppresive effect Effects 0.000 abstract description 3
• 210000003958 hematopoietic stem cell Anatomy 0.000 abstract description 2
• 238000001228 spectrum Methods 0.000 abstract 1
• 210000004027 cell Anatomy 0.000 description 196
• 108090000623 proteins and genes Proteins 0.000 description 109
• 102000004169 proteins and genes Human genes 0.000 description 73
• 235000018102 proteins Nutrition 0.000 description 72
• 125000000539 amino acid group Chemical group 0.000 description 70
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 63
• 108020004414 DNA Proteins 0.000 description 59
• 102000053602 DNA Human genes 0.000 description 58
• 230000014509 gene expression Effects 0.000 description 47
• 102000040430 polynucleotide Human genes 0.000 description 47
• 108091033319 polynucleotide Proteins 0.000 description 47
• 239000002157 polynucleotide Substances 0.000 description 47
• 241000699670 Mus sp. Species 0.000 description 45
• 230000000694 effects Effects 0.000 description 45
• 102000005962 receptors Human genes 0.000 description 45
• 108020003175 receptors Proteins 0.000 description 45
• 208000015181 infectious disease Diseases 0.000 description 43
• 238000012360 testing method Methods 0.000 description 43
• 238000003556 assay Methods 0.000 description 42
• 235000001014 amino acid Nutrition 0.000 description 41
• 230000006698 induction Effects 0.000 description 39
• 239000002502 liposome Substances 0.000 description 37
• 208000006454 hepatitis Diseases 0.000 description 34
• 229940024606 amino acid Drugs 0.000 description 33
• 150000001413 amino acids Chemical class 0.000 description 33
• 239000000203 mixture Substances 0.000 description 32
• 108010076504 Protein Sorting Signals Proteins 0.000 description 29
• 210000002966 serum Anatomy 0.000 description 29
• 101710145151 Interferon lambda receptor 1 Proteins 0.000 description 27
• 102100037971 Interferon lambda receptor 1 Human genes 0.000 description 27
• 239000002609 medium Substances 0.000 description 27
• 230000003248 secreting effect Effects 0.000 description 26
• 241000124008 Mammalia Species 0.000 description 25
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 25
• 241000699666 Mus <mouse, genus> Species 0.000 description 23
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 22
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 22
• 229940079593 drug Drugs 0.000 description 22
• 208000018191 liver inflammation Diseases 0.000 description 21
• 210000001519 tissue Anatomy 0.000 description 21
• 238000009739 binding Methods 0.000 description 20
• 102000039446 nucleic acids Human genes 0.000 description 20
• 108020004707 nucleic acids Proteins 0.000 description 20
• 150000007523 nucleic acids Chemical class 0.000 description 20
• 108020004635 Complementary DNA Proteins 0.000 description 19
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 19
• 241001263478 Norovirus Species 0.000 description 19
• 230000027455 binding Effects 0.000 description 19
• 239000003446 ligand Substances 0.000 description 19
• 230000009467 reduction Effects 0.000 description 19
• 238000006722 reduction reaction Methods 0.000 description 19
• 230000010076 replication Effects 0.000 description 19
• 102000004127 Cytokines Human genes 0.000 description 18
• 108090000695 Cytokines Proteins 0.000 description 18
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 18
• 230000007423 decrease Effects 0.000 description 18
• 201000010099 disease Diseases 0.000 description 18
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 17
• 210000001744 T-lymphocyte Anatomy 0.000 description 17
• 210000003719 b-lymphocyte Anatomy 0.000 description 17
• 238000010804 cDNA synthesis Methods 0.000 description 17
• 230000001684 chronic effect Effects 0.000 description 17
• 239000002299 complementary DNA Substances 0.000 description 17
• 150000001875 compounds Chemical class 0.000 description 17
• 230000000120 cytopathologic effect Effects 0.000 description 17
• 206010022000 influenza Diseases 0.000 description 17
• 239000000523 sample Substances 0.000 description 17
• 108020004705 Codon Proteins 0.000 description 16
• 238000000338 in vitro Methods 0.000 description 16
• 230000005764 inhibitory process Effects 0.000 description 16
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 15
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 15
• 101710199214 Interleukin-10 receptor subunit beta Proteins 0.000 description 15
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 description 15
• 230000001154 acute effect Effects 0.000 description 15
• 208000002672 hepatitis B Diseases 0.000 description 15
• 210000003494 hepatocyte Anatomy 0.000 description 15
• 229920000642 polymer Polymers 0.000 description 15
• 239000013598 vector Substances 0.000 description 15
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 14
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 14
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 14
• 241001465754 Metazoa Species 0.000 description 14
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 14
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 14
• 239000012091 fetal bovine serum Substances 0.000 description 14
• 239000002777 nucleoside Substances 0.000 description 14
• 150000003833 nucleoside derivatives Chemical class 0.000 description 14
• 239000000243 solution Substances 0.000 description 14
• 210000000952 spleen Anatomy 0.000 description 14
• 230000001225 therapeutic effect Effects 0.000 description 14
• 241000588724 Escherichia coli Species 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 13
• 210000004369 blood Anatomy 0.000 description 13
• 239000008280 blood Substances 0.000 description 13
• 239000012634 fragment Substances 0.000 description 13
• 102000057952 human IFNL1 Human genes 0.000 description 13
• 239000003112 inhibitor Substances 0.000 description 13
• 108700023801 mouse interferon-lambda Proteins 0.000 description 13
• 239000002773 nucleotide Substances 0.000 description 13
• 125000003729 nucleotide group Chemical group 0.000 description 13
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 13
• 239000002953 phosphate buffered saline Substances 0.000 description 13
• 241000701161 unidentified adenovirus Species 0.000 description 13
• 239000007924 injection Substances 0.000 description 12
• 238000002347 injection Methods 0.000 description 12
• 238000002560 therapeutic procedure Methods 0.000 description 12
• 241000991587 Enterovirus C Species 0.000 description 11
• 101100232738 Gallus gallus IFNL3 gene Proteins 0.000 description 11
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 11
• 108091006905 Human Serum Albumin Proteins 0.000 description 11
• 102000008100 Human Serum Albumin Human genes 0.000 description 11
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 11
• 238000013459 approach Methods 0.000 description 11
• 230000000295 complement effect Effects 0.000 description 11
• 238000009396 hybridization Methods 0.000 description 11
• 238000007912 intraperitoneal administration Methods 0.000 description 11
• 108020004999 messenger RNA Proteins 0.000 description 11
• 230000035772 mutation Effects 0.000 description 11
• 241000701447 unidentified baculovirus Species 0.000 description 11
• 239000003981 vehicle Substances 0.000 description 11
• 108010002350 Interleukin-2 Proteins 0.000 description 10
• 102000000588 Interleukin-2 Human genes 0.000 description 10
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 10
• -1 P-globin Proteins 0.000 description 10
• 239000002253 acid Substances 0.000 description 10
• 230000000692 anti-sense effect Effects 0.000 description 10
• 238000010790 dilution Methods 0.000 description 10
• 239000012895 dilution Substances 0.000 description 10
• 238000001727 in vivo Methods 0.000 description 10
• 229940047124 interferons Drugs 0.000 description 10
• 210000004072 lung Anatomy 0.000 description 10
• 239000013641 positive control Substances 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 230000002829 reductive effect Effects 0.000 description 10
• 230000000284 resting effect Effects 0.000 description 10
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 9
• 241001529916 Hepatitis GB virus B Species 0.000 description 9
• 101000852865 Homo sapiens Interferon alpha/beta receptor 2 Proteins 0.000 description 9
• 241000725303 Human immunodeficiency virus Species 0.000 description 9
• 102100036718 Interferon alpha/beta receptor 2 Human genes 0.000 description 9
• 108090000467 Interferon-beta Proteins 0.000 description 9
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 9
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
• 241000725643 Respiratory syncytial virus Species 0.000 description 9
• 241000710886 West Nile virus Species 0.000 description 9
• 238000004458 analytical method Methods 0.000 description 9
• 238000004113 cell culture Methods 0.000 description 9
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 9
• 102000003675 cytokine receptors Human genes 0.000 description 9
• 108010057085 cytokine receptors Proteins 0.000 description 9
• 238000011534 incubation Methods 0.000 description 9
• 230000006320 pegylation Effects 0.000 description 9
• 230000011664 signaling Effects 0.000 description 9
• 231100001274 therapeutic index Toxicity 0.000 description 9
• 238000001890 transfection Methods 0.000 description 9
• 238000012546 transfer Methods 0.000 description 9
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 8
• 108010082126 Alanine transaminase Proteins 0.000 description 8
• 241000725619 Dengue virus Species 0.000 description 8
• 102000016911 Deoxyribonucleases Human genes 0.000 description 8
• 108010053770 Deoxyribonucleases Proteins 0.000 description 8
• 241000282412 Homo Species 0.000 description 8
• 101001002469 Homo sapiens Interferon lambda-2 Proteins 0.000 description 8
• 241001502974 Human gammaherpesvirus 8 Species 0.000 description 8
• 102000003996 Interferon-beta Human genes 0.000 description 8
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
• 108091028043 Nucleic acid sequence Proteins 0.000 description 8
• 238000007792 addition Methods 0.000 description 8
• 239000002585 base Substances 0.000 description 8
• 230000004071 biological effect Effects 0.000 description 8
• 230000004927 fusion Effects 0.000 description 8
• 108020001507 fusion proteins Proteins 0.000 description 8
• 102000037865 fusion proteins Human genes 0.000 description 8
• 231100000283 hepatitis Toxicity 0.000 description 8
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 8
• 102000057945 human IFNL2 Human genes 0.000 description 8
• 108010045648 interferon omega 1 Proteins 0.000 description 8
• 229960001388 interferon-beta Drugs 0.000 description 8
• 230000004044 response Effects 0.000 description 8
• 230000000405 serological effect Effects 0.000 description 8
• 238000006467 substitution reaction Methods 0.000 description 8
• 231100000419 toxicity Toxicity 0.000 description 8
• 230000001988 toxicity Effects 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 241000712461 unidentified influenza virus Species 0.000 description 8
• 238000005406 washing Methods 0.000 description 8
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 7
• 229940123014 DNA polymerase inhibitor Drugs 0.000 description 7
• 206010016654 Fibrosis Diseases 0.000 description 7
• 102000008070 Interferon-gamma Human genes 0.000 description 7
• 108010074328 Interferon-gamma Proteins 0.000 description 7
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 7
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 7
• 241000712910 Pichinde mammarenavirus Species 0.000 description 7
• 229940122277 RNA polymerase inhibitor Drugs 0.000 description 7
• 239000000427 antigen Substances 0.000 description 7
• 108091007433 antigens Proteins 0.000 description 7
• 102000036639 antigens Human genes 0.000 description 7
• 230000030833 cell death Effects 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 208000019425 cirrhosis of liver Diseases 0.000 description 7
• 210000004443 dendritic cell Anatomy 0.000 description 7
• 239000013604 expression vector Substances 0.000 description 7
• 230000008935 histological improvement Effects 0.000 description 7
• 229960003130 interferon gamma Drugs 0.000 description 7
• 210000003734 kidney Anatomy 0.000 description 7
• 210000005229 liver cell Anatomy 0.000 description 7
• 230000000241 respiratory effect Effects 0.000 description 7
• 230000019491 signal transduction Effects 0.000 description 7
• 238000011830 transgenic mouse model Methods 0.000 description 7
• 241000709661 Enterovirus Species 0.000 description 6
• 108091029865 Exogenous DNA Proteins 0.000 description 6
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 6
• 239000004473 Threonine Substances 0.000 description 6
• 241000700618 Vaccinia virus Species 0.000 description 6
• 235000004279 alanine Nutrition 0.000 description 6
• 230000037396 body weight Effects 0.000 description 6
• 230000003833 cell viability Effects 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• 238000012377 drug delivery Methods 0.000 description 6
• 239000000975 dye Substances 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 230000002401 inhibitory effect Effects 0.000 description 6
• 210000000265 leukocyte Anatomy 0.000 description 6
• 108020001756 ligand binding domains Proteins 0.000 description 6
• 210000002540 macrophage Anatomy 0.000 description 6
• 239000012528 membrane Substances 0.000 description 6
• 239000004005 microsphere Substances 0.000 description 6
• 239000013642 negative control Substances 0.000 description 6
• PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 6
• 238000003753 real-time PCR Methods 0.000 description 6
• 238000005932 reductive alkylation reaction Methods 0.000 description 6
• 230000009870 specific binding Effects 0.000 description 6
• 230000000638 stimulation Effects 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 235000008521 threonine Nutrition 0.000 description 6
• 230000000007 visual effect Effects 0.000 description 6
• 206010008909 Chronic Hepatitis Diseases 0.000 description 5
• 241000710188 Encephalomyocarditis virus Species 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 241001646716 Escherichia coli K-12 Species 0.000 description 5
• 208000005577 Gastroenteritis Diseases 0.000 description 5
• 102000002227 Interferon Type I Human genes 0.000 description 5
• 108010014726 Interferon Type I Proteins 0.000 description 5
• 108010086140 Interferon alpha-beta Receptor Proteins 0.000 description 5
• 102000007438 Interferon alpha-beta Receptor Human genes 0.000 description 5
• 239000005089 Luciferase Substances 0.000 description 5
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 5
• 238000005917 acylation reaction Methods 0.000 description 5
• 230000002391 anti-complement effect Effects 0.000 description 5
• 108010008730 anticomplement Proteins 0.000 description 5
• 235000009582 asparagine Nutrition 0.000 description 5
• 244000309464 bull Species 0.000 description 5
• 239000003638 chemical reducing agent Substances 0.000 description 5
• 230000007882 cirrhosis Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• 230000018109 developmental process Effects 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
• 208000005252 hepatitis A Diseases 0.000 description 5
• 238000009169 immunotherapy Methods 0.000 description 5
• 230000002458 infectious effect Effects 0.000 description 5
• 230000003993 interaction Effects 0.000 description 5
• 230000003834 intracellular effect Effects 0.000 description 5
• 150000002632 lipids Chemical class 0.000 description 5
• 208000019423 liver disease Diseases 0.000 description 5
• 210000004962 mammalian cell Anatomy 0.000 description 5
• 230000004048 modification Effects 0.000 description 5
• 238000012986 modification Methods 0.000 description 5
• 210000001616 monocyte Anatomy 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 230000007170 pathology Effects 0.000 description 5
• 230000037361 pathway Effects 0.000 description 5
• 238000012552 review Methods 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000029812 viral genome replication Effects 0.000 description 5
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
• 238000010600 3H thymidine incorporation assay Methods 0.000 description 4
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
• 241000709687 Coxsackievirus Species 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 208000000832 Equine Encephalomyelitis Diseases 0.000 description 4
• 241000283073 Equus caballus Species 0.000 description 4
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
• 208000005331 Hepatitis D Diseases 0.000 description 4
• 241000238631 Hexapoda Species 0.000 description 4
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
• 102000003814 Interleukin-10 Human genes 0.000 description 4
• 108090000174 Interleukin-10 Proteins 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• 241000699660 Mus musculus Species 0.000 description 4
• BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
• 206010046865 Vaccinia virus infection Diseases 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 229960001230 asparagine Drugs 0.000 description 4
• 210000001185 bone marrow Anatomy 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 235000014633 carbohydrates Nutrition 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 230000004663 cell proliferation Effects 0.000 description 4
• 238000010367 cloning Methods 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 238000000855 fermentation Methods 0.000 description 4
• 230000004151 fermentation Effects 0.000 description 4
• 239000012737 fresh medium Substances 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 239000005090 green fluorescent protein Substances 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 210000003000 inclusion body Anatomy 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 238000001990 intravenous administration Methods 0.000 description 4
• 229960001627 lamivudine Drugs 0.000 description 4
• JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 230000002503 metabolic effect Effects 0.000 description 4
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
• 238000011330 nucleic acid test Methods 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000008194 pharmaceutical composition Substances 0.000 description 4
• 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 235000004400 serine Nutrition 0.000 description 4
• 238000009097 single-agent therapy Methods 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 230000008685 targeting Effects 0.000 description 4
• 230000009261 transgenic effect Effects 0.000 description 4
• 241001529453 unidentified herpesvirus Species 0.000 description 4
• 229960005486 vaccine Drugs 0.000 description 4
• 208000007089 vaccinia Diseases 0.000 description 4
• 239000004474 valine Substances 0.000 description 4
• 235000014393 valine Nutrition 0.000 description 4
• 208000030507 AIDS Diseases 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 238000011740 C57BL/6 mouse Methods 0.000 description 3
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 3
• 102100034330 Chromaffin granule amine transporter Human genes 0.000 description 3
• 208000001490 Dengue Diseases 0.000 description 3
• 206010012310 Dengue fever Diseases 0.000 description 3
• XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 description 3
• 102000002090 Fibronectin type III Human genes 0.000 description 3
• 108050009401 Fibronectin type III Proteins 0.000 description 3
• KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 3
• 101000641221 Homo sapiens Chromaffin granule amine transporter Proteins 0.000 description 3
• 101001002466 Homo sapiens Interferon lambda-3 Proteins 0.000 description 3
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 3
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 102100030703 Interleukin-22 Human genes 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 108060001084 Luciferase Proteins 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 241001105894 Murine norovirus Species 0.000 description 3
• 241001452677 Ogataea methanolica Species 0.000 description 3
• 108700026244 Open Reading Frames Proteins 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• 238000002944 PCR assay Methods 0.000 description 3
• 108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 description 3
• 108010059712 Pronase Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 3
• 241000256251 Spodoptera frugiperda Species 0.000 description 3
• 206010047700 Vomiting Diseases 0.000 description 3
• 241001492404 Woodchuck hepatitis virus Species 0.000 description 3
• 241000710772 Yellow fever virus Species 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000010933 acylation Effects 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 150000001299 aldehydes Chemical class 0.000 description 3
• 238000005804 alkylation reaction Methods 0.000 description 3
• KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 108010044715 asialofetuin Proteins 0.000 description 3
• 239000011324 bead Substances 0.000 description 3
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 3
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 3
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
• 229960000074 biopharmaceutical Drugs 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 210000002798 bone marrow cell Anatomy 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 238000013270 controlled release Methods 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 208000025729 dengue disease Diseases 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 230000006334 disulfide bridging Effects 0.000 description 3
• 241001493065 dsRNA viruses Species 0.000 description 3
• 229960000366 emtricitabine Drugs 0.000 description 3
• 206010014599 encephalitis Diseases 0.000 description 3
• 229960000980 entecavir Drugs 0.000 description 3
• YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 230000001036 exonucleolytic effect Effects 0.000 description 3
• 239000007850 fluorescent dye Substances 0.000 description 3
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
• 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 3
• 239000000710 homodimer Substances 0.000 description 3
• 102000057946 human IFNL3 Human genes 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 230000036039 immunity Effects 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 230000015788 innate immune response Effects 0.000 description 3
• 210000003292 kidney cell Anatomy 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 238000012544 monitoring process Methods 0.000 description 3
• 210000000865 mononuclear phagocyte system Anatomy 0.000 description 3
• 210000000822 natural killer cell Anatomy 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 239000008188 pellet Substances 0.000 description 3
• 150000003904 phospholipids Chemical class 0.000 description 3
• 239000013612 plasmid Substances 0.000 description 3
• 229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 239000007790 solid phase Substances 0.000 description 3
• 229960005322 streptomycin Drugs 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 229960005311 telbivudine Drugs 0.000 description 3
• IQFYYKKMVGJFEH-CSMHCCOUSA-N telbivudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-CSMHCCOUSA-N 0.000 description 3
• 229960004556 tenofovir Drugs 0.000 description 3
• VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• 230000010415 tropism Effects 0.000 description 3
• HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 3
• 210000003462 vein Anatomy 0.000 description 3
• 210000003501 vero cell Anatomy 0.000 description 3
• 230000008673 vomiting Effects 0.000 description 3
• 229940051021 yellow-fever virus Drugs 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 2
• 208000007788 Acute Liver Failure Diseases 0.000 description 2
• 206010001258 Adenoviral infections Diseases 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• 239000004254 Ammonium phosphate Substances 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 206010006448 Bronchiolitis Diseases 0.000 description 2
• 102100032912 CD44 antigen Human genes 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 101710205625 Capsid protein p24 Proteins 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 229920002307 Dextran Polymers 0.000 description 2
• 206010012735 Diarrhoea Diseases 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 241000710781 Flaviviridae Species 0.000 description 2
• 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 2
• 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 244000068988 Glycine max Species 0.000 description 2
• 235000010469 Glycine max Nutrition 0.000 description 2
• 241000700739 Hepadnaviridae Species 0.000 description 2
• 206010019668 Hepatic fibrosis Diseases 0.000 description 2
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 2
• 101001003149 Homo sapiens Interleukin-10 receptor subunit beta Proteins 0.000 description 2
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 2
• 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 2
• 101150003028 Hprt1 gene Proteins 0.000 description 2
• 101150106931 IFNG gene Proteins 0.000 description 2
• 108010054016 IL-TIF IL-10-related T cell-derived inducible factor Proteins 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 108010002386 Interleukin-3 Proteins 0.000 description 2
• 102100039064 Interleukin-3 Human genes 0.000 description 2
• 108010002616 Interleukin-5 Proteins 0.000 description 2
• 108010002586 Interleukin-7 Proteins 0.000 description 2
• 241000235058 Komagataella pastoris Species 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• 102100033467 L-selectin Human genes 0.000 description 2
• 206010067125 Liver injury Diseases 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 102000043129 MHC class I family Human genes 0.000 description 2
• 108091054437 MHC class I family Proteins 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• 241000283923 Marmota monax Species 0.000 description 2
• 241000272327 Murine norovirus 1 Species 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 206010028813 Nausea Diseases 0.000 description 2
• 206010028851 Necrosis Diseases 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 241000369774 Norwalk-like virus Species 0.000 description 2
• 102000011931 Nucleoproteins Human genes 0.000 description 2
• 108010061100 Nucleoproteins Proteins 0.000 description 2
• 241000282579 Pan Species 0.000 description 2
• 241000282577 Pan troglodytes Species 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 208000037581 Persistent Infection Diseases 0.000 description 2
• 101710177166 Phosphoprotein Proteins 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 206010035664 Pneumonia Diseases 0.000 description 2
• 101710182846 Polyhedrin Proteins 0.000 description 2
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 2
• 108091034057 RNA (poly(A)) Proteins 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
• 101710149279 Small delta antigen Proteins 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 101710120037 Toxin CcdB Proteins 0.000 description 2
• 102100022563 Tubulin polymerization-promoting protein Human genes 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
• 208000012873 acute gastroenteritis Diseases 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 210000001552 airway epithelial cell Anatomy 0.000 description 2
• 230000029936 alkylation Effects 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
• 235000019289 ammonium phosphates Nutrition 0.000 description 2
• 230000007416 antiviral immune response Effects 0.000 description 2
• 210000001367 artery Anatomy 0.000 description 2
• 239000012911 assay medium Substances 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 239000004202 carbamide Substances 0.000 description 2
• 125000000837 carbohydrate group Chemical group 0.000 description 2
• 229910002091 carbon monoxide Inorganic materials 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 230000022534 cell killing Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 208000020403 chronic hepatitis C virus infection Diseases 0.000 description 2
• 238000005352 clarification Methods 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• 150000001945 cysteines Chemical class 0.000 description 2
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 229920006237 degradable polymer Polymers 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 231100000673 dose–response relationship Toxicity 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 239000003797 essential amino acid Substances 0.000 description 2
• 235000020776 essential amino acid Nutrition 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 230000005284 excitation Effects 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 230000004761 fibrosis Effects 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 229930182830 galactose Natural products 0.000 description 2
• 229960002963 ganciclovir Drugs 0.000 description 2
• IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 229960000789 guanidine hydrochloride Drugs 0.000 description 2
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 230000002440 hepatic effect Effects 0.000 description 2
• 102000053391 human F Human genes 0.000 description 2
• 108700031895 human F Proteins 0.000 description 2
• 102000055525 human IL10RB Human genes 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 238000013394 immunophenotyping Methods 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 208000037797 influenza A Diseases 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 108040006870 interleukin-10 receptor activity proteins Proteins 0.000 description 2
• 108010074108 interleukin-21 Proteins 0.000 description 2
• 108010074109 interleukin-22 Proteins 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 239000008263 liquid aerosol Substances 0.000 description 2
• 210000005228 liver tissue Anatomy 0.000 description 2
• 238000000464 low-speed centrifugation Methods 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 241001515942 marmosets Species 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 108700029353 mouse Ifna Proteins 0.000 description 2
• 230000008693 nausea Effects 0.000 description 2
• 230000017074 necrotic cell death Effects 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 238000005192 partition Methods 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 108010086652 phytohemagglutinin-P Proteins 0.000 description 2
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
• 229920002704 polyhistidine Polymers 0.000 description 2
• 238000003752 polymerase chain reaction Methods 0.000 description 2
• 230000000644 propagated effect Effects 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 206010043554 thrombocytopenia Diseases 0.000 description 2
• 238000004448 titration Methods 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• KUHSEZKIEJYEHN-BXRBKJIMSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.OC[C@H](N)C(O)=O KUHSEZKIEJYEHN-BXRBKJIMSA-N 0.000 description 1
• RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
• 208000029483 Acquired immunodeficiency Diseases 0.000 description 1
• 241000228431 Acremonium chrysogenum Species 0.000 description 1
• 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000004176 Alphacoronavirus Species 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• 206010059313 Anogenital warts Diseases 0.000 description 1
• 241000256844 Apis mellifera Species 0.000 description 1
• 108010002913 Asialoglycoproteins Proteins 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 238000011725 BALB/c mouse Methods 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 206010056375 Bile duct obstruction Diseases 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 206010065553 Bone marrow failure Diseases 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 208000006339 Caliciviridae Infections Diseases 0.000 description 1
• 241000222128 Candida maltosa Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 206010062746 Carditis Diseases 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102000011632 Caseins Human genes 0.000 description 1
• 108010076119 Caseins Proteins 0.000 description 1
• 241000863012 Caulobacter Species 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 206010008635 Cholestasis Diseases 0.000 description 1
• 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
• 206010057573 Chronic hepatic failure Diseases 0.000 description 1
• 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
• 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 208000000907 Condylomata Acuminata Diseases 0.000 description 1
• 102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 208000010334 End Stage Liver Disease Diseases 0.000 description 1
• 208000004232 Enteritis Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 206010015108 Epstein-Barr virus infection Diseases 0.000 description 1
• 108010075944 Erythropoietin Receptors Proteins 0.000 description 1
• 102100036509 Erythropoietin receptor Human genes 0.000 description 1
• 108700039887 Essential Genes Proteins 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 108091007413 Extracellular RNA Proteins 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 102100028701 General vesicular transport factor p115 Human genes 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 102000000340 Glucosyltransferases Human genes 0.000 description 1
• 108010055629 Glucosyltransferases Proteins 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 206010019233 Headaches Diseases 0.000 description 1
• 208000018565 Hemochromatosis Diseases 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 241000711557 Hepacivirus Species 0.000 description 1
• 206010073069 Hepatic cancer Diseases 0.000 description 1
• 206010019663 Hepatic failure Diseases 0.000 description 1
• 206010019799 Hepatitis viral Diseases 0.000 description 1
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
• 208000001688 Herpes Genitalis Diseases 0.000 description 1
• 208000004898 Herpes Labialis Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 101000878664 Homo sapiens Corticotropin-releasing factor receptor 2 Proteins 0.000 description 1
• 101000767151 Homo sapiens General vesicular transport factor p115 Proteins 0.000 description 1
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
• 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
• 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 1
• 101000741885 Homo sapiens Protection of telomeres protein 1 Proteins 0.000 description 1
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 235000003332 Ilex aquifolium Nutrition 0.000 description 1
• 241000209027 Ilex aquifolium Species 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 206010022004 Influenza like illness Diseases 0.000 description 1
• 108010060231 Insect Proteins Proteins 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102100039879 Interleukin-19 Human genes 0.000 description 1
• 108050009288 Interleukin-19 Proteins 0.000 description 1
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 1
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
• 102000000704 Interleukin-7 Human genes 0.000 description 1
• 244000285963 Kluyveromyces fragilis Species 0.000 description 1
• 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
• 241001138401 Kluyveromyces lactis Species 0.000 description 1
• 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 206010023927 Lassa fever Diseases 0.000 description 1
• 102100039564 Leukosialin Human genes 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 231100000070 MTS assay Toxicity 0.000 description 1
• 238000000719 MTS assay Methods 0.000 description 1
• 101710141347 Major envelope glycoprotein Proteins 0.000 description 1
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
• 208000001940 Massive Hepatic Necrosis Diseases 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 108010036176 Melitten Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 206010027260 Meningitis viral Diseases 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 208000000112 Myalgia Diseases 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• 208000009525 Myocarditis Diseases 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 241000320412 Ogataea angusta Species 0.000 description 1
• 206010067152 Oral herpes Diseases 0.000 description 1
• 102000016978 Orphan receptors Human genes 0.000 description 1
• 108070000031 Orphan receptors Proteins 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 229920001734 PEG propionaldehyde Polymers 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010033661 Pancytopenia Diseases 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 108010064851 Plant Proteins Proteins 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 102100038745 Protection of telomeres protein 1 Human genes 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 206010038707 Respiratory papilloma Diseases 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 108010044012 STAT1 Transcription Factor Proteins 0.000 description 1
• 239000002262 Schiff base Substances 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 208000001203 Smallpox Diseases 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 108010068542 Somatotropin Receptors Proteins 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 241000187438 Streptomyces fradiae Species 0.000 description 1
• 241000187398 Streptomyces lividans Species 0.000 description 1
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
• 108091027544 Subgenomic mRNA Proteins 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 108010000499 Thromboplastin Proteins 0.000 description 1
• 108090000253 Thyrotropin Receptors Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 241001664469 Tibicina haematodes Species 0.000 description 1
• 102100030859 Tissue factor Human genes 0.000 description 1
• 108090000340 Transaminases Proteins 0.000 description 1
• 241000255993 Trichoplusia ni Species 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 241000221566 Ustilago Species 0.000 description 1
• 241000870995 Variola Species 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 206010058874 Viraemia Diseases 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 208000018839 Wilson disease Diseases 0.000 description 1
• 208000003152 Yellow Fever Diseases 0.000 description 1
• 229920002494 Zein Polymers 0.000 description 1
• 238000002679 ablation Methods 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• 229960004150 aciclovir Drugs 0.000 description 1
• MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000004721 adaptive immunity Effects 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 201000007930 alcohol dependence Diseases 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 235000021120 animal protein Nutrition 0.000 description 1
• 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
• 201000004201 anogenital venereal wart Diseases 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 238000002832 anti-viral assay Methods 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 238000011225 antiretroviral therapy Methods 0.000 description 1
• 229940124977 antiviral medication Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 229920001718 aryloxy-PEG Polymers 0.000 description 1
• 150000001508 asparagines Chemical class 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 229920001743 bis-succinimidyl carbonate PEG Polymers 0.000 description 1
• WVMHLYQJPRXKLC-UHFFFAOYSA-N borane;n,n-dimethylmethanamine Chemical compound B.CN(C)C WVMHLYQJPRXKLC-UHFFFAOYSA-N 0.000 description 1
• RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical compound [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 description 1
• NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 229940021722 caseins Drugs 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 238000005341 cation exchange Methods 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 230000000973 chemotherapeutic effect Effects 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 208000011444 chronic liver failure Diseases 0.000 description 1
• 231100000012 chronic liver injury Toxicity 0.000 description 1
• 238000001142 circular dichroism spectrum Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 238000005094 computer simulation Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 229940095074 cyclic amp Drugs 0.000 description 1
• 208000024389 cytopenia Diseases 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000000779 depleting effect Effects 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 238000002050 diffraction method Methods 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 210000000959 ear middle Anatomy 0.000 description 1
• 150000002061 ecdysteroids Chemical class 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 244000000021 enteric pathogen Species 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 229960002089 ferrous chloride Drugs 0.000 description 1
• 239000011790 ferrous sulphate Substances 0.000 description 1
• 235000003891 ferrous sulphate Nutrition 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 201000004946 genital herpes Diseases 0.000 description 1
• 210000004392 genitalia Anatomy 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 231100000869 headache Toxicity 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
• 208000031169 hemorrhagic disease Diseases 0.000 description 1
• 231100000234 hepatic damage Toxicity 0.000 description 1
• 206010019692 hepatic necrosis Diseases 0.000 description 1
• 230000001553 hepatotropic effect Effects 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 239000008241 heterogeneous mixture Substances 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 230000002962 histologic effect Effects 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 239000011539 homogenization buffer Substances 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 230000008102 immune modulation Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 238000009177 immunoglobulin therapy Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 208000022760 infectious otitis media Diseases 0.000 description 1
• 208000021646 inflammation of heart layer Diseases 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 150000004001 inositols Chemical class 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 108010085650 interferon gamma receptor Proteins 0.000 description 1
• 229940076144 interleukin-10 Drugs 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 210000004020 intracellular membrane Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
• BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
• 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 238000009533 lab test Methods 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 201000002364 leukopenia Diseases 0.000 description 1
• 231100001022 leukopenia Toxicity 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000012317 liver biopsy Methods 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 230000008818 liver damage Effects 0.000 description 1
• 208000007903 liver failure Diseases 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 208000030208 low-grade fever Diseases 0.000 description 1
• 238000002794 lymphocyte assay Methods 0.000 description 1
• 210000000207 lymphocyte subset Anatomy 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 235000011147 magnesium chloride Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
• GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
• 230000000394 mitotic effect Effects 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 108700014891 mouse IL29 Proteins 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 230000036457 multidrug resistance Effects 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 239000002077 nanosphere Substances 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 230000011999 negative regulation of cell killing Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 231100000587 neutral red assay Toxicity 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 208000004235 neutropenia Diseases 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 244000309711 non-enveloped viruses Species 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 238000012856 packing Methods 0.000 description 1
• 230000000242 pagocytic effect Effects 0.000 description 1
• 210000002741 palatine tonsil Anatomy 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 238000012510 peptide mapping method Methods 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
• 235000021118 plant-derived protein Nutrition 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 108010070958 polyaconitylated human serum albumin Proteins 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 229920001451 polypropylene glycol Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 229910000160 potassium phosphate Inorganic materials 0.000 description 1
• 235000011009 potassium phosphates Nutrition 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 229940021993 prophylactic vaccine Drugs 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 230000012743 protein tagging Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000004153 renaturation Methods 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000008593 response to virus Effects 0.000 description 1
• 230000003307 reticuloendothelial effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 230000001932 seasonal effect Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 239000003001 serine protease inhibitor Substances 0.000 description 1
• 238000012807 shake-flask culturing Methods 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 235000011008 sodium phosphates Nutrition 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 210000004500 stellate cell Anatomy 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000013595 supernatant sample Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 230000003867 tiredness Effects 0.000 description 1
• 208000016255 tiredness Diseases 0.000 description 1
• 229960001295 tocopherol Drugs 0.000 description 1
• 239000011732 tocopherol Substances 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000816 toxic dose Toxicity 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 102000014898 transaminase activity proteins Human genes 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 229920001733 tresyl monomethoxy PEG Polymers 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
• 229960001661 ursodiol Drugs 0.000 description 1
• 230000002477 vacuolizing effect Effects 0.000 description 1
• 201000001862 viral hepatitis Diseases 0.000 description 1
• 201000010044 viral meningitis Diseases 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1
• 229940093612 zein Drugs 0.000 description 1
• 239000005019 zein Substances 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1